ADDEX THERAPEUTICS LTD's ticker is ADXN and the CUSIP is 00654J107. A total of 11 filers reported holding ADDEX THERAPEUTICS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $408,293 | -35.5% | 180,000 | 0.0% | 0.03% | -33.3% |
| Q2 2023 | $632,885 | -43.1% | 180,000 | -96.8% | 0.05% | -37.7% |
| Q1 2023 | $1,112,792 | +881.1% | 5,648,690 | +423.0% | 0.08% | +1183.3% |
| Q4 2022 | $113,418 | -86.3% | 1,080,000 | -80.9% | 0.01% | -85.4% |
| Q3 2022 | $830,000 | -23.4% | 5,648,690 | +500.0% | 0.04% | -26.8% |
| Q2 2022 | $1,083,000 | +18.5% | 941,448 | +423.0% | 0.06% | +115.4% |
| Q1 2022 | $914,000 | +345.9% | 180,000 | 0.0% | 0.03% | +550.0% |
| Q4 2021 | $205,000 | -87.4% | 180,000 | 0.0% | 0.00% | -78.9% |
| Q3 2021 | $1,622,000 | -90.6% | 180,000 | 0.0% | 0.02% | -91.5% |
| Q2 2021 | $17,208,000 | – | 180,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 5,648,690 | $830,000 | 0.04% |
| New Leaf Venture Partners, L.L.C. | 50,000 | $40,000 | 0.02% |
| FNY Investment Advisers, LLC | 22,500 | $17,000 | 0.01% |
| ARMISTICE CAPITAL, LLC | 320,000 | $256,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 19,957 | $16,000 | 0.00% |
| Citadel Advisors | 12,803 | $10,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 12,076 | $10,000 | 0.00% |
| Renaissance Technologies | 29,547 | $24,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 124 | $0 | 0.00% |